S. Mcgaffigan et Dl. Bliwise, THE TREATMENT OF SUNDOWNING - A SELECTIVE REVIEW OF PHARMACOLOGICAL AND NONPHARMACOLOGICAL STUDIES, Drugs & aging, 10(1), 1997, pp. 10-17
Sundowning refers to episodes of agitated behaviour that are more freq
uent or are more severe at night. Although the effects of different ps
ychoactive medications on agitated behaviour in dementia patients have
been documented in hundreds of reports over the last 30 years, less t
han 20 studies make explicit reference to time of day for which outcom
e measures were derived, and even fewer have also examined sleep as an
outcome. Thus, despite varying claims of efficacy and effectiveness f
or various medications, there are few data to support informed managem
ent of disruptive nocturnal behaviour in these patients. In this brief
article, we selectively review those few studies explicitly mentionin
g temporal dimensions of behavioural outcome, including some newer stu
dies of unconventional types of treatment that may be useful for the t
reatment of sundowning. We conclude that future pharmacological studie
s should systematically assess behaviour throughout the 24-hour day to
provide outcome data relevant to this phenomenon.